These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1299 related items for PubMed ID: 31587602

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
    Savarese G, Jonsson Å, Hallberg AC, Dahlström U, Edner M, Lund LH.
    Int J Cardiol; 2020 Jan 01; 298():59-65. PubMed ID: 31521440
    [Abstract] [Full Text] [Related]

  • 23. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U, Dahlström U, Fu M, Lund LH.
    JACC Heart Fail; 2017 Aug 01; 5(8):565-574. PubMed ID: 28711451
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D, Uijl A, Vedin O, Strömberg A, Faxén UL, Rosano GMC, Sinagra G, Dahlström U, Savarese G.
    JACC Heart Fail; 2019 Jun 01; 7(6):505-515. PubMed ID: 31146874
    [Abstract] [Full Text] [Related]

  • 31. Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta-analysis.
    Kroshian G, Joseph J, Kinlay S, Peralta AO, Hoffmeister PS, Singh JP, Yuyun MF.
    J Cardiovasc Electrophysiol; 2024 Apr 01; 35(4):715-726. PubMed ID: 38348517
    [Abstract] [Full Text] [Related]

  • 32. Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Choi KH, Lee GY, Choi JO, Jeon ES, Lee HY, Cho HJ, Lee SE, Kim MS, Kim JJ, Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ, Yoo BS, Kim KH, Park HY, Cho MC, Oh BH.
    Heart; 2018 Mar 01; 104(6):525-532. PubMed ID: 28982721
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y, Watanabe E, Lip GYH, Koshikawa M, Ichikawa T, Kawai M, Harada M, Inamasu J, Ozaki Y.
    Heart Vessels; 2018 Apr 01; 33(4):403-412. PubMed ID: 29067492
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP, Gamble GD, Ling LH, Sim D, Leong KTG, Yeo PSD, Ong HY, Jaufeerally F, Ng TP, Cameron VA, Poppe K, Lund M, Devlin G, Troughton R, Richards AM, Doughty RN.
    Eur Heart J; 2018 May 21; 39(20):1770-1780. PubMed ID: 29390051
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL, Uijl A, Dekker FW, Lund LH, Savarese G, Carrero JJ.
    Circ Heart Fail; 2020 Nov 21; 13(11):e007180. PubMed ID: 33070637
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.